

Fundamental dimension Equity attribute | BNZILeader $1.910.00% Cap $361.3KP/E -0.0x QuantScore49/100 | BZAIPeer $0.2393▼-2.72% Cap $34.66MP/E -0.4x QuantScore45/100 | CXAIPeer $1.83▼-1.61% Cap $4.28MP/E -0.1x QuantScore38/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
49/100 |
45/100 |
39/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 67/100 | 50/100 |
Health Piotroski, Altman Z, leverage & liquidity | 15/100 | 50/100 | 25/100 |
Growth Revenue / earnings growth & margins | 81/100 | 26/100 | 39/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 35/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.4x | -0.1x |
Forward P/E (next FY) | -0.1x | -0.3x | -0.2x |
EV / EBITDA (TTM) | -0.3x | 0.0x | -0.2x |
Price / Sales | 0.0x | 0.7x | 1.2x |
Price / Free Cash Flow | -0.0x | -0.4x | -0.4x |
PEG ratio | -0.00 | -0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 2 / 9 | 2 / 9 |
Altman Z-Score | -7.74 (Distress) | -14.14 (Distress) | -5.48 (Distress) |
Total debt / equity | 0.55 | 0.00 | 0.58 |
Quick ratio | 0.1x | 3.2x | 1.6x |
Interest coverage | -10.2x | — | -23.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +168.6% | +2386.0% | -35.8% |
Net income growth YoY | +28.6% | -238.1% | +30.6% |
Gross margin (TTM) | 78.3% | 11.7% | 34.4% |
Operating margin (FY) | -151.8% | -237.6% | -336.7% |
FCF margin (FY) | -129.2% | -212.8% | -226.5% |
5. Trailing price performancePrice change over period |
1M return | +7.9% | -52.9% | -29.1% |
3M return | -36.5% | -73.5% | -66.5% |
6M return | -91.8% | -88.1% | -77.7% |
Year to date | -90.1% | -87.7% | -89.0% |
1Y return | -96.1% | -94.9% | -95.3% |
3Y return | -100.0% | -98.4% | -97.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-601.24 -31578.5% premium | $17.57 +7242.1% upside | $4.05 +121.2% upside |
Wall Street consensus target | — — | $2.50 +944.7% · range $1.00–$4.50 | — — |
Consensus stance | 100% Buy0% Hold0% Sell | 33% Buy67% Hold0% Sell | — |